Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Beam Therapeutics
BEAM
$2.84B
| $4.61M | ﹤0.01% |
144,532
+28,903
| +25% | +$938K |
|
|
HI
1377
DELISTED
Hillenbrand
HI
| $4.6M | ﹤0.01% |
89,773
+54,222
| +153% | +$2.61M |
|
|
CPE
1378
DELISTED
Callon Petroleum Company
CPE
| $4.6M | ﹤0.01% |
131,260
+56,452
| +75% | +$1.89M |
|
1379
Independence Realty Trust
IRT
$4.07B
| $4.59M | ﹤0.01% |
252,148
-251,945
| -50% | -$4.3M |
|
|
UCB
1380
United Community Banks
UCB
$4.28B
| $4.59M | ﹤0.01% |
183,599
+80,251
| +78% | +$1.99M |
|
1381
CALL
Zoetis
ZTS
$30.4B
| $4.58M | ﹤0.01% |
+26,600
| New | +$4.6M |
|
1382
Virgin Galactic
SPCE
$398M
| $4.57M | ﹤0.01% |
58,884
-19,174
| -25% | -$1.52M |
|
1383
Utz Brands
UTZ
$1.25B
| $4.57M | ﹤0.01% |
279,171
+244,654
| +709% | +$4.2M |
|
1384
CALL
RTX Corp
RTX
$301B
| $4.56M | ﹤0.01% |
+46,600
| New | +$4.56M |
|
1385
PTC Therapeutics
PTCT
$6.12B
| $4.56M | ﹤0.01% |
112,215
+27,124
| +32% | +$1.33M |
|
1386
Acadia Pharmaceuticals
ACAD
$5.04B
| $4.54M | ﹤0.01% |
189,540
+23,862
| +14% | +$530K |
|
1387
Celsius Holdings
CELH
$7.1B
| $4.54M | ﹤0.01% |
91,272
-111,303
| -55% | -$4.43M |
|
|
RCM
1388
DELISTED
R1 RCM Inc. Common Stock
RCM
| $4.54M | ﹤0.01% |
245,867
-78,505
| -24% | -$1.28M |
|
1389
Veracyte
VCYT
$3.8B
| $4.51M | ﹤0.01% |
177,220
+31,517
| +22% | +$764K |
|
1390
Brunswick
BC
$5.29B
| $4.51M | ﹤0.01% |
52,054
+26,598
| +104% | +$2.17M |
|
1391
Vir Biotechnology
VIR
$1.49B
| $4.5M | ﹤0.01% |
183,527
-48,975
| -21% | -$1.23M |
|
1392
Agios Pharmaceuticals
AGIO
$1.93B
| $4.5M | ﹤0.01% |
158,725
+62,896
| +66% | +$1.57M |
|
1393
Axos Financial
AX
$5.68B
| $4.48M | ﹤0.01% |
113,610
+55,492
| +95% | +$2.15M |
|
1394
Insmed
INSM
$28.6B
| $4.47M | ﹤0.01% |
211,916
-725,024
| -77% | -$13.8M |
|
1395
PUT
Valero Energy
VLO
$85.9B
| $4.46M | ﹤0.01% |
+38,000
| New | +$4.42M |
|
1396
e.l.f. Beauty
ELF
$5.81B
| $4.45M | ﹤0.01% |
38,933
-3,948
| -9% | -$380K |
|
1397
CALL
United Airlines
UAL
$42B
| $4.39M | ﹤0.01% |
80,000
| – | – |
|
1398
MasTec
MTZ
$21.9B
| $4.38M | ﹤0.01% |
37,129
+27,527
| +287% | +$2.7M |
|
1399
Dave & Buster's
PLAY
$357M
| $4.38M | ﹤0.01% |
98,225
-613,560
| -86% | -$22.4M |
|
|
MDC
1400
DELISTED
M.D.C. Holdings, Inc.
MDC
| $4.38M | ﹤0.01% |
93,557
-11,633
| -11% | -$484K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.